Needham Reiterates Buy on Merit Medical Systems, Maintains $109 Price Target
Portfolio Pulse from Benzinga Newsdesk
Needham analyst Mike Matson has reiterated a Buy rating on Merit Medical Systems (NASDAQ:MMSI) and maintained a price target of $109.
October 31, 2024 | 1:57 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Needham analyst Mike Matson has reiterated a Buy rating on Merit Medical Systems and maintained a price target of $109, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $109 price target by a reputable analyst suggests a positive outlook for Merit Medical Systems. This can boost investor confidence and potentially lead to a short-term increase in stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100